Thymidine phosphorylase (platelet-derived endothelial cell growth factor), microvessel density and clinical outcome in hepatocellular carcinoma

Journal of Hepatology

Volumn 29, Issue 2, 1998, Pages 290-299

  Yamamoto, Akitaka ^a   Dhar, Dipok Kumar ^a   El Assal, Osama Nazmy ^a   Masahiko, Igarashi ^a   Hideki, Tabara ^a   Naofumi, Nagasue ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

Angiogenesis; CD34; Factor VIII; Hepatocellular carcinoma; Microvessel density; Platelet derived endothelial cell growth factor; Prognosis; Sinusoid

Indexed keywords

ANGIOGENIC FACTOR; CD34 ANTIGEN; MONOCLONAL ANTIBODY; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; THYMIDINE PHOSPHORYLASE; VON WILLEBRAND FACTOR;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0032147155     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80015-9     Document Type: Article

References (46)

1. Folkman J, Shing Y. Angiogenesis. J Biol Chem. 267:1992;10931-10934.
2. Bicknell R, Harris AL. Novel growth regulatory factors and tumor angiogenesis. Eur J Cancer. 27:1991;781-785.
3. Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol. 3:1992;65-71.
4. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst. 82:1990;4-6.
5. Bosari S, Lee AKC, DeLellis RA, Wiley BD, Heatley GJ, Silverman ML. Microvessel quantitation and prognosis in invasive breasts carcinoma. Hum Pathol. 23:1992;755-761.
6. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst. 84:1992;1875-1887.
7. Maeda K, Chung YS, Takatsuka S, Ogawa Y, Sawada T, Yamashita Y, et al. Tumor angiogenesis as a predictor of recurrence in gastric carcinoma. J Clin Oncol. 13:1995;477-481.
8. Tanigawa N, Amaya H, Matsumura M, Shimomatsuya T, Horiuchi T, Muraoka R, et al. Extent of tumor vascularization correlates with prognosis and hematogenous metastasis in gastric carcinomas. Cancer Res. 56:1996;2671-2676.
9. Frank RE, Saclarides TJ, Leurgans S, Speziale NJ, Drab EA, Rubin DB. Tumor angiogenesis as a predictor of recurrence and survival in patients with node-negative colon cancer. Ann Surg. 222:1995;695-699.
10. Bossi P, Viale G, Lee AKC, Alfano RM, Coggi G, Bosari S. Angiogenesis in colorectal tumors: microvessel quantitation in adenomas and carcinomas with clinicopathological correlations. Cancer Res. 55:1995;5049-5053.
11. Macchiarini P, Fontanini G, Hardin MJ, Squartini F, Angeletti GA. Relation of neovascularizaiton to metastasis of non-small-cell lung cancer. Lancet. 340:1992;145-146.
12. Wakui S, Furusato M, Itoh T, Sasaki H, Akiyama A, Kinoshita I, et al. Tumor angiogenesis in prostatic carcinoma with and without bone marrow metastasis: a morphometric study. J Pathol. 168:1992;257-262.
13. Brawer MK, Deering RE, Brown M, Preston SD, Bigler SA. Predictors of pathologic stage in prostatic carcinoma: the role of neovascularity. Cancer. 73:1994;678-687.
14. Hollingsworth HC, Kohn EC, Steinberg SM, Rothenberg ML, Merino MJ. Tumor angiogenesis in advanced stage ovarian carcinoma. Am J Pathol. 147:1995;33-41.
15. Iltzsch MH, Kouni MH, Cha S. Kinetic studies of thymidine phosphorylase from mouse liver. Biochemistry. 24:1985;6799-807.
16. Friedkin M, Roberts D. The enzymatic synthesis of nucleosides. Thymidine phosphorylase in mammalian tissue. J Biol Chem. 207:1953;245-56.
17. Krenitsky TA, Koszalka GW, Tuttle JV. Purine nucleoside synthesis, an efficient method employing nucleoside phosphorylase. Biochemistry. 20:1981;3615-3621.
18. Gallo RC, Perry S, Breitman TR. The enzymatic mechanisms for deoxythymidine synthesis in human leukocytes. J Biol Chem. 242:1967;5059-5068.
19. Krenitsky TA. Pentosyl transfer mechanisms of the mammalian nucleoside phosphorylases. J Biol Chem. 243:1968;2871-2875.
20. Zimmerman M, Seidenberg J. Deoxyribosil transfer. J Biol Chem. 230:1964;2618-2621.
21. Miyazono K, Okabe T, Urabe A, Takaku F, Heldin CH. Purification and properties of an endothelial cell growth factor from human platelets. J Biol Chem. 262:1987;4098-4103.
22. Ishikawa F, Miyazono K, Hellman U, Drexler H, Wernstedt C, Hagiwara K, et al. Identification of angiogenic activity ad the cloning and expression of platelet-derived endothelial cell growth factor. Nature. 338:1989;557-562.
23. Furukawa T, Yoshimura A, Sumizawa T, Haraguchi M, Akiyama SI. Angiogenic factor. Nature. 356:1992;668.
24. Haraguchi M, Miyadera K, Uemura K, Sumizawa T, Furukawa T, Yamada K, et al. Angiogenic activity of enzymes. Nature. 368:1994;198.
25. Heldin NE, Usuki K, Bergh J, Westermark B, Heldin CH. Differential expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human lung carcinomal cell lines. Br J Cancer. 68:1993;708-711.
26. Toi M, Hoshina S, Taniguchi T, Yamamoto Y, Ishituka H, Tominaga T. Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer. Int J Cancer (Pred Oncol). 64:1995;79-82.
27. Fox SB, Westwood M, Moghaddam A, Comley M, Turkey H, Whitehouse RM, et al. The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is upregulated in breast cancer epithelium and endothelium. Br J Cancer. 73:1996;278-280.
28. Maeda K, Chung YS, Ogawa Y, Takatsuka S, Kang SM, Ogawa M, et al. Thymidine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma. Br J Cancer. 73:1996;884-888.
29. Takebayashi Y, Yamada K, Maruyama I, Fujii RI, Akiyama SI, Aikou T. The expression of thymidine phosphorylase and thrombomodulin in human colorectal carcinomas. Cancer Letter. 92:1995;1-7.
30. Takebayashi Y, Yamada K, Ohmoto Y, Sameshima T, Miyadera K, Yamada Y, et al. The correlation of thymidine phosphorylase activity with the expression of interleukin 1α, interferon α and interferon γ in human colorectal carcinoma. Cancer Letter. 95:1995;57-62.
31. Takebayashi Y, Yamada K, Miyadera K, Sumizawa T, Furukawa T, Kinoshita F, et al. The activity and expression of thymidine phosphorylase in human solid tumours. Eur J Cancer. 32A:1996;1227-1232.
32. Busch C, Malmstrom PO, Norlen BJ, Sallstrom J, Brodin T, Lundblad A. A grading system for the immunostaining of A, B, and H blood group isoantigens in bladder carcinoma. Anticancer REs. 8:1988;81-88.
33. Watanabe T, Katsura Y, Yoshitake A, Masataki H, Mori T. Image processor for analytical pathology. J Toxicol Pathol. 7:1994;353-361.
34. Haratake J, Scheuer PJ. An immunohistochemical and ultrastructural study of the sinusoids in hepatocellular carcinoma. Cancer. 65:1990;1985-1993.
35. Maeda T, Adachi E, Kajiyama K, Takenaka K, Honda H, Sugimachi K, et al. CD34 expression in endothelial cells of small hepatocellular: its correlation with tumor progression and angiographic findings. J Gastroenterol Hepatol. 10:1995;650-654.
36. Ruck P, Xiao JC, Kaiserling E. Immunoreactivity of sinusoids in hepatocellular carcinoma: an immunohistochemical study using lectin UEA-1 and antibodies against endothelial markers, including CD34. Arch Pathol Lab Med. 119:1995;173-178.
37. Haratake J, Hisaoka M, Yamamoto O, Horie A. An ultrastructural comparison of sinusoids in hepatocellular carcinoma, adenomatous hyperplasia, and fetal liver. Arch Pathol Lab Med. 116:1992;67-70.
38. Sakamoto M, Ino Y, Fujii T, Hirohashi S. Phenotype changes in tumor vessels associated with the progression of hepatocellular carcinoma. Jpn J Clin Oncol. 23:1993;098-104.
39. Bhattacharya S, Davidson B, Dhillon AP. Blood supply of early hepatocellular carcinoma. Semin Liver Dis. 15:1995;390-401.
40. Mazzanti R, Messerini L, Monsacchi L, Buzzeli G, Zignego AL, Foschi M, et al. Chronic viral hepatitis induced by hepatitis C but not hepatitis B virus infection correlates with increased liver angiogenesis. Hepatology. 25:1997;229-234.
41. Ikeda K, Saitoh S, Koida I, Arase Y, Tsubota A, Chayama K, et al. A multivariate analysis of risk factors for hepatocellular carcinomas; a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology. 18:1993;47-53.
42. Takano S, Yokosuka O, Imazeki F, Tagawa M, Omata M. Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients. Hepatology. 21:1995;560-655.
43. Farinati F, Caridin R, D'Errico A, DeMaria N, Naccarato R, Cecchetto A, et al. Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIBI Ki67 in archival material: the role of etiology, disease activity, iron, and lipid peroxidation. Hepatology. 23:1996;1468-1475.
44. Battegay EJ. Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects. J Mol Med. 73:1995;333-346.
45. White CW, Wolf SJ, Korones DN, Sondheimer HM, Tosi MF, Yu A. Treatment of childhood angiomatous diseases with recombinant interferon-2a. J Pediatr. 118:1991;59-66.
46. O'Reilly MA, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell. 79:1994;315-328.